$ALKS 4/A SEC Filings

Filed On	Filing
22 May 2026	Form 4/A: Gaynor Richard, Director Granted 11,538 Non Qualified Stock Option (Right to Buy) · Granted 5,409 Restricted Stock Unit Award
22 May 2026	Form 4/A: Cooke Shane, Director Granted 11,538 Non Qualified Stock Option (Right to Buy) · Granted 5,409 Restricted Stock Unit Award
15 Jan 2021	Form 4/A: Hopkinson Craig C., EVP R&D, Chief Medical Officer Received 6,875 shares by exercise or conversion
27 Jan 2015	Form 4/A: Pugh Gordon G, SVP, COO & CRO, Alkermes, Inc. Gave 46,321 shares as a gift · Acquired 46,321 shares (Gift)
18 Jan 2013	Form 4/A: Ehrich Elliot, SVP, R&D & CMO, Alkermes, Inc. Received 40,000 shares by exercise or conversion ($470K)
21 Sep 2011	Form 4/A: Pugh Gordon G, SVP, COO & CRO, Alkermes, Inc. Returned 24,027 shares to the issuer · Disposed of 48,016 Incentive Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 418,234 Non Qualified Stock Option (Right to Buy) (Disposition to Issuer) · 3 more
21 Sep 2011	Form 4/A: Skaletsky Mark B, Director Returned 5,000 shares to the issuer · Disposed of 159,000 Non Qualified Stock Option (Right to Buy) (Disposition to Issuer)
21 Sep 2011	Form 4/A: Pops Richard F, Director Disposed of 24,375 Restricted Stock Unit Award (Disposition to Issuer)

Comments